DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Procopio G, Bamias A, Schmidinger M. et al.
Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL Study).
Ann Oncol 2018;
29 (Suppl. 08) viii303-viii331
We do not assume any responsibility for the contents of the web pages of other providers.